Tactile Systems Technology, Inc. Interest Expense Nonoperating
Tactile Systems Technology, Inc. (TCMD) reported Interest Expense Nonoperating of $19.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-10
- Tactile Systems Technology, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $19.00K, a 95.37% decline year-over-year.
- Tactile Systems Technology, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $28.00K, a 93.40% decline year-over-year.
- Tactile Systems Technology, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $11.00K, a 97.66% decline year-over-year.
- Tactile Systems Technology, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $193.00K, a 62.67% decline year-over-year.
- Tactile Systems Technology, Inc. interest expense nonoperating for fiscal 2025 was $1.04M, a 50.22% decline from fiscal 2024.
- Tactile Systems Technology, Inc. interest expense nonoperating for fiscal 2024 was $2.08M, a 49.72% decline from fiscal 2023.
- Tactile Systems Technology, Inc. interest expense nonoperating for fiscal 2023 was $4.15M, a 48.74% increase from fiscal 2022.
- Tactile Systems Technology, Inc. interest expense nonoperating for fiscal 2022 was $2.79M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.00K 10-Q · filed 2026-08-10 | $47.00K 10-Q · filed 2026-08-10 | $58.00K derived: sum of 3 quarters · filed 2026-08-10 | $251.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $28.00K 10-Q · filed 2026-05-04 | $39.00K derived: sum of 2 quarters · filed 2026-05-04 | $232.00K derived: sum of 3 quarters · filed 2026-05-04 | $642.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $204.00K derived: sum of 2 quarters · filed 2026-02-17 | $614.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.04M 10-K · filed 2026-02-17 |
| 2025-09-30 | $193.00K 10-Q · filed 2025-11-03 | $603.00K derived: sum of 2 quarters · filed 2026-08-10 | $1.03M 10-Q · filed 2025-11-03 | $1.50M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $410.00K 10-Q · filed 2026-08-10 | $834.00K 10-Q · filed 2026-08-10 | $1.30M derived: sum of 3 quarters · filed 2026-08-10 | $1.82M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $424.00K 10-Q · filed 2026-05-04 | $895.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.41M derived: sum of 3 quarters · filed 2026-05-04 | $1.94M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $471.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $988.00K derived: sum of 2 quarters · filed 2026-02-17 | $1.52M derived: sum of 3 quarters · filed 2026-02-17 | $2.08M 10-K · filed 2026-02-17 |
| 2024-09-30 | $517.00K 10-Q · filed 2025-11-03 | $1.05M derived: sum of 2 quarters · filed 2025-11-03 | $1.61M 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $529.00K 10-Q · filed 2025-08-04 | $1.10M 10-Q · filed 2025-08-04 | ||
| 2024-03-31 | $567.00K 10-Q · filed 2025-05-05 | |||
| 2023-12-31 | $4.15M 10-K · filed 2026-02-17 | |||
| 2022-12-31 | $2.79M 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |